Tag Archives: ParadigmShifting

Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device

A Ladenburg Thalmann report covered the asset, product market and financial projections of this Florida-based company. In an Aug. 30 research note, analyst Jeffrey Cohen reported that Ladenburg Thalmann initiated coverage on medical device company Motus GI Holdings Inc. (MOTS:NASDAQ), with a Buy rating and a $14.50 per share target price. The current share price is about $6.68. Motus plans ...

Read More »

Coverage Initiated on Firm with Paradigm-Shifting Colonoscopy Device

A Ladenburg Thalmann report covered the asset, product market and financial projections of this Florida-based company. In an Aug. 30 research note, analyst Jeffrey Cohen reported that Ladenburg Thalmann initiated coverage on medical device company Motus GI Holdings Inc. (MOTS:NASDAQ), with a Buy rating and a $14.50 per share target price. The current share price is about $6.68. Motus plans ...

Read More »